ProMS+

Biomarker1 paper2 findings

Associations

Ovarian cancer detection

upin silico1

1 study

ProMS+ predicts ovarian cancer detection in silico (AUC 0.983, PPV 0.201).
In silicosimulated high-risk population, OC prevalence = 1%n = 100,000
Development and validation of a serum peptidomic signature for early detection of asymptomatic ovarian cancer: A multi-center prospective study · Cell reports. Medicine · 28 Aug 2026

Early-stage ovarian cancer detection

upin humans1

1 study

ProMS+ predicts early-stage ovarian cancer detection in humans (AUC 0.993).
Human trialearly-stage OC detectionn = 159
Development and validation of a serum peptidomic signature for early detection of asymptomatic ovarian cancer: A multi-center prospective study · Cell reports. Medicine · 28 Aug 2026

Frontiers in Public HealthReview30 Sep

European Geriatric MedicineHuman trial22 Sep

Respiration; International Review of Thoracic DiseasesHumans9 Sep

Cell Reports MedicineHumans28 Aug

AAIC 2025 AbstractHumans23 Dec